File Download
There are no files associated with this item.
Supplementary
- Citations:
- Appears in Collections:
Article: Influence of interleukin-1 gene polymorphism on the outcome of supportive periodontal therapy explored by a multi-factorial periodontal risk assessment model (PRA).
Title | Influence of interleukin-1 gene polymorphism on the outcome of supportive periodontal therapy explored by a multi-factorial periodontal risk assessment model (PRA). |
---|---|
Authors | |
Keywords | Alveolar bone height Bleeding on probing Interleukin-1 polymorphism Multi-functional risk model Periodontal risk assessment Supportive periodontal therapy |
Issue Date | 2003 |
Publisher | Quintessence Publishing Co Ltd. The Journal's web site is located at http://www.quintessencepublishing.co.uk/catalog/product_info.php?cPath=3&products_id=239 |
Citation | Oral Health Prev Dent, 2003, v. 1 n. 1, p. 17-27 How to Cite? |
Abstract | BACKGROUND: Multi-factorial risk models have been proposed to enhance the ability to predict risk for the progression of treated chronic periodontitis. AIMS: to study if the outcomes of supportive periodontal therapy (SPT) based on a multi-factorial periodontal risk assessment are influenced by IL-1 gene polymorphism (IP) status. MATERIAL AND METHODS: Information about the IP and smoking status, clinical periodontal conditions and age related bone level measurements were used to calculate a peridontal risk assessment model (PRA). The surface area of this diagram was calculated for 224 subjects who had participated in an SPT program over four years. Baseline and 4-year follow-up data were studied in relation to the IP status. RESULTS: Positive IP tests were obtained for 80/224 (35.7%) of the subjects. At baseline the mean PRA for the IP positive group was 79.9 units, which at year four had increased to 81.3 units (mean diff: 1.4 units, S.D.+/-16.5, p<0.45, 95% CI: 2.3 to 5.1). At baseline and year four the mean PRA for the IP negative group was 44.2 and 38.6 units, respectively. This difference was statistically significant (mean diff: 5.6, S.D.+/-16.1, p<0.001, 95% CI: 3.0 to 8.3). Independent t-tests confirmed that the IP status was significantly associated with a less favorable change in PRA over the four-year period (PRA difference: 7.04, t=3.01, p<0.003, 95% CI: 2.4 to 11.65). Bleeding on probing, and probing depth values alone did not differ between positive and negative IP status. Regression analysis demonstrated that the best-fit model for change in PRA included bleeding on probing at baseline, IP status, proportional alveolar bone loss in relation to the age, and gender. CONCLUSION: The PRA allowed the assessment of the outcomes of SPT therapy. Subjects with positive IP did not respond to individualized SPT as favorably as did IP negative subjects. |
Persistent Identifier | http://hdl.handle.net/10722/154356 |
ISSN | 2023 Impact Factor: 1.4 2023 SCImago Journal Rankings: 0.420 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Persson, GR | en_US |
dc.contributor.author | Matuliené, G | en_US |
dc.contributor.author | Ramseier, CA | en_US |
dc.contributor.author | Persson, RE | en_US |
dc.contributor.author | Tonetti, MS | en_US |
dc.contributor.author | Lang, NP | en_US |
dc.date.accessioned | 2012-08-08T08:24:51Z | - |
dc.date.available | 2012-08-08T08:24:51Z | - |
dc.date.issued | 2003 | en_US |
dc.identifier.citation | Oral Health Prev Dent, 2003, v. 1 n. 1, p. 17-27 | en_US |
dc.identifier.issn | 1602-1622 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/154356 | - |
dc.description.abstract | BACKGROUND: Multi-factorial risk models have been proposed to enhance the ability to predict risk for the progression of treated chronic periodontitis. AIMS: to study if the outcomes of supportive periodontal therapy (SPT) based on a multi-factorial periodontal risk assessment are influenced by IL-1 gene polymorphism (IP) status. MATERIAL AND METHODS: Information about the IP and smoking status, clinical periodontal conditions and age related bone level measurements were used to calculate a peridontal risk assessment model (PRA). The surface area of this diagram was calculated for 224 subjects who had participated in an SPT program over four years. Baseline and 4-year follow-up data were studied in relation to the IP status. RESULTS: Positive IP tests were obtained for 80/224 (35.7%) of the subjects. At baseline the mean PRA for the IP positive group was 79.9 units, which at year four had increased to 81.3 units (mean diff: 1.4 units, S.D.+/-16.5, p<0.45, 95% CI: 2.3 to 5.1). At baseline and year four the mean PRA for the IP negative group was 44.2 and 38.6 units, respectively. This difference was statistically significant (mean diff: 5.6, S.D.+/-16.1, p<0.001, 95% CI: 3.0 to 8.3). Independent t-tests confirmed that the IP status was significantly associated with a less favorable change in PRA over the four-year period (PRA difference: 7.04, t=3.01, p<0.003, 95% CI: 2.4 to 11.65). Bleeding on probing, and probing depth values alone did not differ between positive and negative IP status. Regression analysis demonstrated that the best-fit model for change in PRA included bleeding on probing at baseline, IP status, proportional alveolar bone loss in relation to the age, and gender. CONCLUSION: The PRA allowed the assessment of the outcomes of SPT therapy. Subjects with positive IP did not respond to individualized SPT as favorably as did IP negative subjects. | en_US |
dc.language | eng | en_US |
dc.publisher | Quintessence Publishing Co Ltd. The Journal's web site is located at http://www.quintessencepublishing.co.uk/catalog/product_info.php?cPath=3&products_id=239 | en_US |
dc.relation.ispartof | Oral Health Prev Dent | en_US |
dc.subject | Alveolar bone height | - |
dc.subject | Bleeding on probing | - |
dc.subject | Interleukin-1 polymorphism | - |
dc.subject | Multi-functional risk model | - |
dc.subject | Periodontal risk assessment | - |
dc.subject | Supportive periodontal therapy | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Age Factors | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 And Over | en_US |
dc.subject.mesh | Alveolar Bone Loss - Classification | en_US |
dc.subject.mesh | Cohort Studies | en_US |
dc.subject.mesh | Disease Progression | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Gingival Hemorrhage - Classification | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interleukin-1 - Genetics | en_US |
dc.subject.mesh | Longitudinal Studies | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Periodontal Pocket - Classification | en_US |
dc.subject.mesh | Periodontitis - Etiology - Therapy | en_US |
dc.subject.mesh | Polymorphism, Genetic - Genetics | en_US |
dc.subject.mesh | Retrospective Studies | en_US |
dc.subject.mesh | Risk Assessment | en_US |
dc.subject.mesh | Sex Factors | en_US |
dc.subject.mesh | Smoking | en_US |
dc.subject.mesh | Tooth Loss - Classification | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Influence of interleukin-1 gene polymorphism on the outcome of supportive periodontal therapy explored by a multi-factorial periodontal risk assessment model (PRA). | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lang, NP:nplang@hkucc.hku.hk | en_US |
dc.identifier.authority | Lang, NP=rp00031 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 15643745 | - |
dc.identifier.scopus | eid_2-s2.0-2442465357 | en_US |
dc.identifier.volume | 1 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 17 | en_US |
dc.identifier.epage | 27 | en_US |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Persson, GR=7101853867 | en_US |
dc.identifier.scopusauthorid | Matuliené, G=7801433083 | en_US |
dc.identifier.scopusauthorid | Ramseier, CA=8921696800 | en_US |
dc.identifier.scopusauthorid | Persson, RE=35584452800 | en_US |
dc.identifier.scopusauthorid | Tonetti, MS=35602248900 | en_US |
dc.identifier.scopusauthorid | Lang, NP=7201577367 | en_US |
dc.identifier.issnl | 1602-1622 | - |